Stephen M Akers
Overview
Explore the profile of Stephen M Akers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller N, Seman B, Akers S, Povroznik J, Brundage K, Fang W, et al.
Pediatr Res
. 2022 Mar;
92(6):1566-1574.
PMID: 35288639
Background: The increasing magnitude of the opioid crisis and rising rates of neonatal abstinence syndrome (NAS) diagnoses highlight the need for increased research into how maternal substance use during pregnancy...
2.
Seman B, Vance J, Akers S, Robinson C
J Cell Sci
. 2021 Feb;
134(5).
PMID: 33589502
Low-density granulocytes (LDGs) are found abundantly in neonatal blood; however, there is limited mechanistic understanding of LDG interactions with bacteria and innate immune cells during acute infection. We aimed to...
3.
Akers S, Kinney K, Butcher M, Moise A
J Pediatr Pharmacol Ther
. 2020 Aug;
25(6):547-551.
PMID: 32839659
Late-onset sepsis caused by is a serious and relatively common complication encountered by preterm neonates in NICUs. Typical treatment regimens for invasive methicillin-sensitive (MSSA) include semisynthetic beta lactam antibiotics, such...
4.
Rellick S, OLeary H, Piktel D, Walton C, Fortney J, Akers S, et al.
PLoS One
. 2012 Feb;
7(2):e30758.
PMID: 22363485
Hematopoietic reconstitution, following bone marrow or stem cell transplantation, requires a microenvironment niche capable of supporting both immature progenitors and stem cells with the capacity to differentiate and expand. Osteoblasts...
5.
Akers S, Rellick S, Fortney J, Gibson L
Leuk Res
. 2011 Jan;
35(6):705-11.
PMID: 21269691
CNS infiltration by leukemic cells remains a problematic disease manifestation of acute lymphoblastic leukemia (ALL). Prophylactic regimens for CNS leukemia including intrathecal chemotherapeutics have decreased CNS involvement in ALL, but...
6.
OLeary H, Akers S, Piktel D, Walton C, Fortney J, Martin K, et al.
Cancer Microenviron
. 2011 Jan;
3(1):67-81.
PMID: 21209775
The mechanisms by which the bone marrow microenvironment regulates tumor cell survival are diverse. This study describes the novel observation that in addition to Philadelphia chromosome positive (Ph+) acute lymphoblastic...
7.
VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers
Akers S, OLeary H, Minnear F, Craig M, Vos J, Coad J, et al.
Exp Hematol
. 2010 May;
38(9):733-43.
PMID: 20470859
Objective: Infiltration of the central nervous system (CNS) by leukemia is a problematic disease manifestation of acute lymphoblastic leukemia (ALL). The mechanisms by which leukocytes interact with human brain-derived microvasculature...
8.
Rezaee F, Rellick S, Piedimonte G, Akers S, OLeary H, Martin K, et al.
PLoS One
. 2010 Mar;
5(3):e9690.
PMID: 20300619
Background: The host's response to infection is characterized by altered levels of neurotrophins and an influx of inflammatory cells to sites of injured tissue. Progenitor cells that give rise to...